New Insights into Osteoarthritis Treatment Satisfaction Through Biotherapy Experiences

In a significant development presented at the 146th Chubu Japan Orthopedic Disaster Science Conference in 2026, Dr. Hiroto Hanai from the Medical Corporation Katsujikai, Knee Osteoarthritis Clinic, shared groundbreaking research on the evaluation of treatment effects for osteoarthritis using biotherapy (ASC/PFC-FD™). This study emphasized the importance of understanding how patients perceive their treatment outcomes beyond mere numerical improvements.

Research Background

The treatment of osteoarthritis often relies on established criteria, such as the OMERACT-OARSI guidelines. However, these standards may not fully reflect the patients' subjective experiences of treatment efficacy. Recognizing this gap, the study aimed to explore what aspects of their condition or improvements lead patients to feel a genuine sense of treatment success. In total, 1,080 osteoarthritis patients who underwent biotherapy across seven facilities were tracked over a six-month period post-treatment, analyzing the correlation between various evaluation metrics and the patients' subjective feelings of treatment effects.

Research Findings

The analysis unveiled a compelling insight: the actual final state of the knee is more strongly associated with patient satisfaction than the extent of improvement achieved through treatment. Key factors contributing to high patient satisfaction included:

- Experiencing low levels of pain (measured by the KOOS-Pain index)
- Being able to live without significant awareness of knee issues (as per the KOOS-QOL index)

Discussion

Unlike treatments that provide quick fixes, biotherapy aims for gradual improvement over time, which can make it challenging for patients to appreciate the extent of their improvement. For many patients, the journey involves a slow diminishing awareness of their previous pain levels, while the numerical improvements may not be as easily recognized. This study underscores the need for healthcare providers to move beyond simply tracking clinical numbers. Instead, it stresses the importance of reflecting on the specific symptoms patients faced prior to treatment and their current ability to engage in daily life seamlessly. This shared understanding is crucial for accurately assessing treatment experiences and enhancing overall patient satisfaction.

In light of these findings, the Knee Osteoarthritis Clinic is committed to prioritizing quality of life (QOL) in its approach to diagnosis and treatment. Rather than focusing solely on numerical improvements, the clinic will emphasize whether patients can live without pain and continue engaging in activities they enjoy.

Future Prospects

This research serves as a pivotal reminder of the need to reconsider treatment evaluation methodologies within regenerative medicine and biotherapy. At Katsujikai, ongoing efforts will focus on developing robust indicators that effectively measure patient perceptions and quality of life. Through this patient-centered evaluation, the clinic aims to contribute significantly to improving the overall quality of life for individuals suffering from knee pain.

About the Knee Osteoarthritis Clinic

The Knee Osteoarthritis Clinic specializes in regenerative medicine treatments for knee pain, specifically targeting osteoarthritis. Guided by the ethos of not letting medical care overshadow patients' lives, the clinic not only aims to alleviate pain but also strives to help patients reclaim their individuality and cherished moments in life through comprehensive research and treatment.